These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7817593)

  • 1. [Analysis of pharmacotherapy and it's effectiveness in ischemic heart disease and arterial hypertension, conducted by doctors in specialist and regional outpatient clinics].
    Guzecka-Ruszczyńska E; Czarnecki A
    Wiad Lek; 1994 May; 47(9-10):352-7. PubMed ID: 7817593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monotherapy and combined therapy for ischemic heart disease and hypertension by general practitioners].
    Ruszczyńska E; Czarnecki A
    Przegl Lek; 1994; 51(12):505-9. PubMed ID: 7746885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The work experience of a polyclinic functional diagnosis office in improving the care for patients with arterial hypertension and ischemic heart disease].
    Sivkova SK; Larionov PV
    Ter Arkh; 1993; 65(1):49-52. PubMed ID: 8036573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Means for increasing treatment efficacy in patients with ischemic heart disease].
    Chazov EI
    Ter Arkh; 1997; 69(9):5-10. PubMed ID: 9411827
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
    Kapur V; Chien CV; Fuess JE; Schwarz ER
    Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of hypertensive treatment in outpatient hypertension clinics with different payment status].
    Niegowska J; Niegowska M; Batogowski M; Jasiński B
    Przegl Epidemiol; 2009; 63(1):131-6. PubMed ID: 19522241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of ischemic heart disease: old traditions and new trends].
    Belenkov IuN
    Ter Arkh; 2005; 77(9):5-8. PubMed ID: 16281480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early effects of cardiovascular drugs--do they predict clinical outcomes?
    Carruthers SG
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):107-12. PubMed ID: 8205369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of ischemic heart disease in ambulatory practice].
    Luknárová N; Tesar T
    Ceska Slov Farm; 1997 Jun; 46(3):108-12. PubMed ID: 9440948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New beta-blockers in the treatment of chronic ischaemic heart disease].
    Jankowski P; Kawecka-Jaszcz K; Jastrzebski M
    Przegl Lek; 2004; 61(9):955-61. PubMed ID: 15803908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
    Krasnitskiĭ VB; Aronov DM; Zhidko NI
    Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipoproteinemic states and ischemic heart disease.
    Prusinski L; Eisold JF
    Dent Clin North Am; 1996 Jul; 40(3):563-84. PubMed ID: 8829046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients.
    Ranchord AM; Harding SA; Pidgeon G
    Intern Med J; 2008 May; 38(5):361-4. PubMed ID: 18402563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of perhexiline in ischaemic heart failure.
    Noble MI; Drake-Holland AJ
    Int J Cardiol; 2010 Mar; 139(2):105-6. PubMed ID: 19748138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of heart failure. General practice references for individual treatment].
    Goss F
    MMW Fortschr Med; 2000 Jun; 142(22):30-4. PubMed ID: 10870380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.